ALF GLD Welcomes Dr. Charlton and Dr. Kim to the Medical Advisory Committee!
ALF Great Lakes Division is very excited to welcome Dr. Michael Charlton and Dr. David Kim to the Medical Advisory Committee!
Dr. Michael Charlton:
Dr. Charlton is President of the International Liver Transplant Society and recently joined the University of Chicago as a Professor of Medicine, where he has been appointed Director of the Center for Liver Diseases and Medical Director of the Transplantation Institute. Dr. Charlton previously served as a Professor of Medicine at the Mayo Clinic and at Intermountain Transplant and Regenerative Medicine Center, where he served as Director of Hepatology and Medical Director of Liver Transplantation. He has held editorial roles for leading journals, including, associate editor for Hepatology, Transplantation, American Journal of Transplantation, and Liver Transplantation, and was a founding Associate Editor for Clinical Gastroenterology and Hepatology. He has served as principal investigator on grants from and been a study section member for the National Institutes of Health, including studies of the pathophysiology of nonalcoholic fatty liver disease. He has published over 200 manuscripts and is a lead investigator for national and international clinical trials in viral hepatitis and nonalcoholic steatohepatitis. He serves as a panel member and writer of AASLD Guidelines for the management of hepatitis C and for nonalcoholic steatohepatitis. He is the only physician to serve on both of these panels.
Dr. David Kim
Dr. Kim completed his internal medicine and GI fellowship at Tufts Medical Center, Boston, MA. In 2002, he joined Northwest Gastroenterologists in Arlington Heights, and devoted his clinical practice to the diagnosis and management of liver disease in the community. Dr. Kim has given talks on liver topics at both local and regional conferences and has also moderated symposiums on liver disease awareness. Dr. Kim is also a speaker and serves on the advisory board for several pharmaceutical companies that produce medications that help combat liver disease.
Last Updated on February 8, 2018
Share this page
